EGRAC is not a suitable test of riboflavin status in people with glucose-6-phosphate dehydrogenase (G6PD) deficiency because GR retains FAD leading to higher GR activity and low EGRAC.4 This evidence concerns the gene GSR and G6PD deficiency.